Type 1 diabetes: molecular, cellular and clinical immunology
Eisenbarth, G.S.
Advances in Experimental Medicine and Biology 552: 306-310
2004
ISSN/ISBN: 0065-2598 PMID: 15622970 Document Number: 575170
Document emailed within 1 workday
Related Documents
Małecki, M.; Krolewski, A.S. 2000: Molecular background and clinical characteristics of autosomal dominant type 2 diabetes mellitus Przeglad lekarski 57 Suppl. 3: 13-18Adam, M.; Bardfeld, R. 1973: Clinical immunology and molecular biology of the connective tissue Casopis Lekaru Ceskych 112(50): 1544-1546
Korfel, J.; Kinalska, I.; Rogowski, F.; Citko, A. 1990: Cellular immunity in insulin-dependent diabetes mellitus (type 1) Polski Tygodnik Lekarski 45(19-20): 373-375
Kadowaki, T. 1999: Molecular pathogenesis of type 2 diabetes mellitus Seikagaku. Journal of Japanese Biochemical Society 71(11): 1281-1298
Sacks, D.B.; Lernmark, A. 2001: Molecular manipulation of autoantibody testing in type 1 diabetes: two for one Clinical Chemistry 47(5): 803-804
Tatoń, J. 1989: Molecular pathology of insulin-dependent diabetes mellitus (type I) Polski Tygodnik Lekarski 44(21-22): 475-483
Gorus, F.K. 1996: The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 58(5): 539-586
Decraene, T.; Vandewalle, C.; Pipeleers, D.; Gorus, F.K. 1992: Increased concentrations of total IgM at clinical onset of type 1 (insulin-dependent) diabetes: correlation with IgM binding to cells. the Belgian Diabetes Registry Clinical Chemistry 38(9): 1762-1767
Fischer, H. 1970: Cellular aspects of immunology Arzneimittel-Forschung 20(2): 165-167
Revillard, J.P. 1980: Current concepts of cellular immunology La Revue du Praticien 30(13): 773
Pánczél, P.; Hosszúfalusi, N.; Bornemisza, B.; Horváth, L.; Jánoskuti, L.; Füst, G.; Rajczy, K.; Vatay, A.; Prohászka, Z.; Madácsy, L.; Luczay, A.; Blatniczky, L.; Halmos, T.; Körner, A.; Szilvási, I.; Romics, L. 2001: Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin Orvosi Hetilap 142(46): 2571-2578
Wadström, J.; Gannedahl, G.; Wahlberg, J.; Frödin, L.; Tedbrandt, A.; Berne, C. 1994: Development of type Ii diabetes after combined kidney-pancreas transplantation in a patient with type i (insulin-dependent) diabetes Transplantation Proceedings 26(3): 1761-1762
De Sanctis, V. 2018: Type 1 and Type 2 diabetes in children and adolescents: a public health problem in Qatar. The experience of Pediatric Diabetes Center at Hamad General Hospital (HGH) of Doha Acta Bio-Medica: Atenei Parmensis 89(S5): 5-6
Wagner, A.C.; Williams, J.A. 1994: Low molecular weight GTP-binding proteins: molecular switches regulating diverse cellular functions American Journal of Physiology 266(1 Pt 1): G1-14
Knuth, A.; Kalthoff, H.; Wagener, C.; Zimmermann, W.; Kern, H.; Mach, J.P.; Douillard, J.Y.; Büchler, M. 1988: The Tumor Immunology Study Group: tumor immunology of the gastrointestinal tract--experimental and clinical experiences Zeitschrift für Gastroenterologie. Verhandlungsband 23: 238-251
2003: Normative documents of the Spanish Society for Pediatric Clinical Immunology and Allergology. Minimum requirements for practicing the specialty of pediatric allergy and immunology in a hospital setting Allergologia et Immunopathologia 31(3): 192-197
Clauser, E.; Assan, R. 1993: Insulin resistance and molecular abnormalities of the insulin receptor in type Ii diabetes Journees Annuelles de Diabetologie de l'Hotel-Dieu 1993: 23-36
Ziai, M.R.; Imberti, L.; Nicotra, M.R.; Badaracco, G.; Segatto, O.; Natali, P.G.; Ferrone, S. 1987: Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen Cancer Research 47(9): 2474-2480
Cammarata-Scalisi, F.; Natsuga, K.; Toyonaga, E.; Nishie, W.; Shimizu, H.; Stock, F.; Milano, M.; Petrosino, P.; Arenas de Sotolongo, A.; Medina, Y. 2015: Clinical and molecular findings of pachyonychia congenita type 2 (PC-2) Gaceta Medica de Mexico 151(2): 270-272
Tuomilehto, J.; Lindström, J. 2003: The principal trials for prevention of type 2 diabetes have now confirmed that type 2 diabetes can be prevented by life style changes. Prevention of type 2 diabetes by life style Journees Annuelles de Diabetologie de l'Hotel-Dieu 2003: 77-89